Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Postoperative Analgesia in Microvascular Decompression
NCT07245290Phase 1Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Area Under the Curve of Numerical Rating Scale for Rest Pain. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07245290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245290.